サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563890

持続グルコース・モニタリング・システムの世界市場

Continuous Glucose Monitoring Systems

出版日
ページ情報
英文 202 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
持続グルコース・モニタリング・システムの世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 202 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

持続グルコース・モニタリング・システムの世界市場は2030年までに103億米ドルに到達

2023年に36億米ドルと推定される持続グルコース・モニタリング・システムの世界市場は、分析期間2023-2030年にCAGR 15.9%で成長し、2030年には103億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるセンサ・コンポーネントは、CAGR 14.7％を記録し、分析期間終了時には54億米ドルに達する見込みです。トランスミッタ＆レシーバ・コンポーネント・セグメントは、分析期間中にCAGR 16.8％の成長が見込まれます。

米国市場は推定9億6,510万米ドル、中国はCAGR22.5％で成長予測

米国の持続グルコース・モニタリング・システム市場は、2023年に9億6,510万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに28億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは22.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、それぞれ分析期間中に12.2%と13.0%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR 12.3%で成長すると予測されています。

世界の持続グルコース・モニタリング・システム市場- 主要動向と促進要因のまとめ

持続グルコース・モニタリング・システムは糖尿病管理にどのような革命をもたらしているか？

持続グルコースモニタリング（CGM）システムは、グルコースレベルに関するリアルタイムの洞察を提供することで、糖尿病管理に革命をもたらし、より良い血糖コントロールと、より多くの情報に基づいた治療方針の決定を可能にしています。従来の指を刺す方法とは異なり、CGM装置は皮下に挿入したセンサーでグルコースレベルを継続的に測定し、スマートフォンや専用リーダーからアクセスできるデータを提供します。この技術的進歩により、血糖値のパターンや動向を追跡する能力が大幅に向上し、患者やヘルスケアプロバイダーは治療計画をより効果的に調整できるようになります。CGMシステムが提供する利便性と精度は、正確なインスリン投与を必要とする1型糖尿病患者にとって特に重要です。さらに、人口の高齢化、座りがちなライフスタイル、肥満率の上昇などの要因によって、世界的に糖尿病の有病率が増加しているため、これらの高度なモニタリングシステムの需要が高まっています。

CGMデバイスの未来を形作る技術革新とは？

持続グルコース・モニタリング・システム市場は、デバイスの精度、ユーザーエクスペリエンス、データ分析能力を向上させるいくつかの技術革新によって推進されています。装着時間が長く、キャリブレーションの回数が少ない、より小型で快適なセンサーの開発により、患者のアドヒアランスと満足度が大幅に向上しています。次世代CGMシステムはインスリンポンプと統合し、リアルタイムのグルコース測定値に基づいてインスリン投与を自動化するクローズドループシステムまたは「人工膵臓」セットアップを構築しています。Bluetooth技術とスマートフォンアプリの統合の進歩により、ユーザーはグルコースデータを介護者やヘルスケアプロバイダーと簡単に共有できるようになり、より良い糖尿病管理が促進されています。さらに、潜在的なグルコース値の動向を予測し、高血糖や低血糖を防ぐためのアラートを提供するために、予測分析とAIベースのアルゴリズムが採用されています。このような技術的進歩は、CGMシステムの有効性を高めるだけでなく、糖尿病管理をより積極的かつ個別化したものにしています。

規制当局の承認と償還政策はCGM市場にどのような影響を与えているか？

規制当局の承認と有利な償還政策は、持続グルコース・モニタリング・システム市場の拡大を促進する重要な要因です。近年、米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの規制機関は、患者の転帰を改善し、ヘルスケアコストを削減する可能性を認識し、新しいCGMデバイスの承認を迅速に進めています。このような規制当局の承認により、CGMシステムの安全性と有効性に関して、ヘルスケアプロバイダーと患者の信頼が高まっています。さらに、いくつかの国の保険会社および政府のヘルスケアプログラムは、CGM装置の適用範囲を拡大しており、糖尿病人口のより多くの層がCGM装置にアクセスできるようになっています。CGMシステムの医療保険償還プランへの組み入れが増加していることは、特に常時監視を必要とする高齢者や1型糖尿病患者の間で、より広範な採用と使用を可能にする重要な要因となっています。

持続グルコース・モニタリング・システム市場の成長を促進する要因は？

持続グルコース・モニタリング・システム市場の成長は、糖尿病有病率の上昇、技術の進歩、支持的な規制や償還の枠組みなど、いくつかの要因によって牽引されています。主要な促進要因の1つは、より良い血糖コントロールを達成するためのリアルタイムグルコースモニタリングの利点に関する患者やヘルスケアプロバイダーの意識の高まりです。また、CGMシステムの普及は、デジタルヘルスプラットフォームやモバイルアプリケーションとの統合によって促進されており、ユーザーエンゲージメントの向上やデータ駆動型の洞察が提供されています。さらに、ヘルスケア業界における価値ベースのケアへのシフトは、糖尿病関連の合併症と全体的な医療費を削減する手段として、CGMシステムの使用を促進しています。さらに、CGM機器メーカーとデジタルヘルス企業との戦略的提携が市場を牽引しており、データ分析と人工知能によってこれらの機器の機能を拡張しています。これらの要因が総合的に、世界のCGM市場の堅調な成長見通しに寄与しています。

調査対象企業の例（注目の53社）

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15797

Global Continuous Glucose Monitoring Systems Market to Reach US$10.3 Billion by 2030

The global market for Continuous Glucose Monitoring Systems estimated at US$3.6 Billion in the year 2023, is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2023-2030. Sensors Component, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Transmitters & Receivers Component segment is estimated at 16.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$965.1 Million While China is Forecast to Grow at 22.5% CAGR

The Continuous Glucose Monitoring Systems market in the U.S. is estimated at US$965.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 22.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Global Continuous Glucose Monitoring Systems Market - Key Trends & Drivers Summarized

How Are Continuous Glucose Monitoring Systems Revolutionizing Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are revolutionizing the management of diabetes by providing real-time insights into glucose levels, allowing for better glycemic control and more informed treatment decisions. Unlike traditional finger-prick methods, CGM devices continuously measure glucose levels through a sensor inserted under the skin, offering data that can be accessed via smartphones or dedicated readers. This technological advancement significantly enhances the ability to track blood glucose patterns and trends, enabling patients and healthcare providers to tailor treatment plans more effectively. The convenience and accuracy provided by CGM systems are especially crucial for patients with Type 1 diabetes, who require precise insulin dosing. Furthermore, the increasing prevalence of diabetes globally, driven by factors such as aging populations, sedentary lifestyles, and rising obesity rates, is amplifying the demand for these advanced monitoring systems.

What Technological Innovations Are Shaping The Future Of CGM Devices?

The Continuous Glucose Monitoring systems market is being propelled by several technological innovations that are enhancing device accuracy, user experience, and data analytics capabilities. The development of smaller, more comfortable sensors that provide longer wear times and require fewer calibrations is significantly improving patient adherence and satisfaction. Next-generation CGM systems are integrating with insulin pumps, creating closed-loop systems or “artificial pancreas” setups that automate insulin delivery based on real-time glucose readings. Advances in Bluetooth technology and smartphone app integrations are allowing users to easily share their glucose data with caregivers and healthcare providers, promoting better diabetes management. Furthermore, predictive analytics and AI-based algorithms are being employed to forecast potential glucose level trends, providing alerts to prevent hyperglycemia or hypoglycemia. These technological advancements are not only enhancing the effectiveness of CGM systems but are also making diabetes management more proactive and personalized.

How Are Regulatory Approvals And Reimbursement Policies Impacting The CGM Market?

Regulatory approvals and favorable reimbursement policies are crucial factors driving the expansion of the Continuous Glucose Monitoring systems market. In recent years, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have fast-tracked approvals for new CGM devices, recognizing their potential to improve patient outcomes and reduce healthcare costs. These regulatory endorsements have instilled greater confidence among healthcare providers and patients regarding the safety and efficacy of CGM systems. Additionally, insurance companies and government healthcare programs in several countries are expanding their coverage for CGM devices, making them more accessible to a larger segment of the diabetic population. The increasing inclusion of CGM systems in health insurance reimbursement plans is a key factor enabling broader adoption and use, particularly among the elderly and those with Type 1 diabetes who require constant monitoring.

What Factors Are Driving The Growth Of The Continuous Glucose Monitoring Systems Market?

The growth in the Continuous Glucose Monitoring systems market is driven by several factors, including rising diabetes prevalence, technological advancements, and supportive regulatory and reimbursement frameworks. One of the key drivers is the increasing awareness among patients and healthcare providers about the benefits of real-time glucose monitoring for achieving better glycemic control. The growing adoption of CGM systems is also being fueled by their integration with digital health platforms and mobile applications, which offer enhanced user engagement and data-driven insights. Additionally, the shift toward value-based care in the healthcare industry is promoting the use of CGM systems as a means to reduce diabetes-related complications and overall healthcare costs. Further driving the market are strategic partnerships between CGM device manufacturers and digital health companies, which are expanding the capabilities of these devices through data analytics and artificial intelligence. These factors collectively contribute to the robust growth outlook for the CGM market worldwide.

Select Competitors (Total 53 Featured) -

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Continuous Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Diabetes and Need for Continuous Monitoring
    • Technological Advancements in CGM Device Accuracy and Connectivity
    • Rising Adoption of Wearable Health Monitoring Devices
    • Growing Demand for Non-Invasive Glucose Monitoring Solutions
    • Integration of CGM with Digital Health Platforms and Apps
    • Development of AI-Based Predictive Analysis in Diabetes Management
    • Increasing Awareness and Adoption Among Non-Diabetic Users
    • Expanding Availability of CGM Devices in Emerging Markets
    • Government Reimbursement Policies Supporting CGM Adoption
    • Innovations in Miniaturized and Implantable Glucose Sensors
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Continuous Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Sensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Transmitters & Receivers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Integrated Insulin Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • JAPAN
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CHINA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • EUROPE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • FRANCE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • GERMANY
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • INDIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AFRICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030

IV. COMPETITION